0 XP   0   0   0

Clinuvel Pharmaceuticals Ltd
Buy, Hold or Sell?

I guess you are interested in Clinuvel Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Clinuvel

Let's start. I'm going to help you getting a better view of Clinuvel Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Clinuvel Pharmaceuticals Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Clinuvel Pharmaceuticals Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Clinuvel Pharmaceuticals Ltd. The closing price on 2022-10-03 was A$19.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Clinuvel Pharmaceuticals Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Clinuvel Pharmaceuticals Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Clinuvel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Clinuvel to the Biotechnology industry mean.
  • A Net Profit Margin of 15.0% means that $0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 36.3%. The company is making a huge profit. +2
  • The TTM is 15.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ36.3%TTM15.0%+21.3%
TTM15.0%YOY37.0%-22.0%
TTM15.0%5Y38.4%-23.4%
5Y38.4%10Y-118.9%+157.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ36.3%-242.4%+278.7%
TTM15.0%-275.9%+290.9%
YOY37.0%-342.1%+379.1%
5Y38.4%-475.7%+514.1%
10Y-118.9%-561.7%+442.8%
1.1.2. Return on Assets

Shows how efficient Clinuvel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clinuvel to the Biotechnology industry mean.
  • 6.2% Return on Assets means that Clinuvel generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 10.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM6.2%+4.3%
TTM6.2%YOY9.9%-3.7%
TTM6.2%5Y7.1%-0.9%
5Y7.1%10Y-0.8%+7.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4%-9.7%+20.1%
TTM6.2%-8.7%+14.9%
YOY9.9%-9.2%+19.1%
5Y7.1%-11.5%+18.6%
10Y-0.8%-12.4%+11.6%
1.1.3. Return on Equity

Shows how efficient Clinuvel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clinuvel to the Biotechnology industry mean.
  • 12.0% Return on Equity means the company generated $0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 12.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM6.8%+5.1%
TTM6.8%YOY11.0%-4.2%
TTM6.8%5Y7.8%-0.9%
5Y7.8%10Y-1.4%+9.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0%-11.8%+23.8%
TTM6.8%-11.1%+17.9%
YOY11.0%-10.6%+21.6%
5Y7.8%-13.5%+21.3%
10Y-1.4%-14.5%+13.1%

1.2. Operating Efficiency of Clinuvel Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Clinuvel is operating .

  • Measures how much profit Clinuvel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clinuvel to the Biotechnology industry mean.
  • An Operating Margin of 31.7% means the company generated $0.32  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 31.7%. The company is operating very efficient. +2
  • The TTM is 12.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ31.7%TTM12.7%+19.0%
TTM12.7%YOY22.8%-10.0%
TTM12.7%5Y34.6%-21.8%
5Y34.6%10Y-139.4%+173.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.7%-232.1%+263.8%
TTM12.7%-269.6%+282.3%
YOY22.8%-309.3%+332.1%
5Y34.6%-466.7%+501.3%
10Y-139.4%-572.5%+433.1%
1.2.2. Operating Ratio

Measures how efficient Clinuvel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.2% means that the operating costs are $0.03for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 0.032. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.008. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.032TTM0.008+0.023
TTM0.008YOY0.130-0.121
TTM0.0085Y0.369-0.361
5Y0.36910Y0.596-0.227
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0323.321-3.289
TTM0.0083.542-3.534
YOY0.1303.491-3.361
5Y0.3695.744-5.375
10Y0.5967.007-6.411

1.3. Liquidity of Clinuvel Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Clinuvel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1,023.7% means the company has $10.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 10.237. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.788. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.237TTM12.788-2.551
TTM12.788YOY10.581+2.207
TTM12.7885Y12.631+0.157
5Y12.63110Y8.291+4.339
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2375.266+4.971
TTM12.7886.060+6.728
YOY10.5816.366+4.215
5Y12.6316.692+5.939
10Y8.2916.457+1.834
1.3.2. Quick Ratio

Measures if Clinuvel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 1,002.8% means the company can pay off $10.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 10.028. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.842. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.028TTM6.842+3.186
TTM6.842YOY5.703+1.140
TTM6.8425Y6.554+0.288
5Y6.55410Y4.564+1.990
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0284.055+5.973
TTM6.8424.865+1.977
YOY5.7035.192+0.511
5Y6.5545.275+1.279
10Y4.5644.997-0.433

1.4. Solvency of Clinuvel Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Clinuvel assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.13 means that Clinuvel assets are financed with 12.8% credit (debt) and the remaining percentage (100% - 12.8%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 0.128. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.091. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.128TTM0.091+0.037
TTM0.091YOY0.103-0.012
TTM0.0915Y0.085+0.006
5Y0.08510Y0.115-0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1280.271-0.143
TTM0.0910.269-0.178
YOY0.1030.296-0.193
5Y0.0850.361-0.276
10Y0.1150.399-0.284
1.4.2. Debt to Equity Ratio

Measures if Clinuvel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 14.6% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is 0.146. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.100. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.146TTM0.100+0.046
TTM0.100YOY0.114-0.014
TTM0.1005Y0.093+0.008
5Y0.09310Y0.134-0.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1460.310-0.164
TTM0.1000.311-0.211
YOY0.1140.310-0.196
5Y0.0930.382-0.289
10Y0.1340.438-0.304

2. Market Valuation of Clinuvel Pharmaceuticals Ltd

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Clinuvel.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 34.97 means the investor is paying $34.97 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The EOD is 44.741. Seems overpriced? -1
  • The MRQ is 34.968. Seems overpriced? -1
  • The TTM is 54.596. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD44.741MRQ34.968+9.772
MRQ34.968TTM54.596-19.628
TTM54.596YOY56.302-1.705
TTM54.5965Y52.786+1.811
5Y52.78610Y25.184+27.602
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD44.741-2.115+46.856
MRQ34.968-2.332+37.300
TTM54.596-3.889+58.485
YOY56.302-5.087+61.389
5Y52.786-3.697+56.483
10Y25.184-3.390+28.574
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Clinuvel.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The MRQ is -2.330. Very Bad. -2
  • The TTM is -0.031. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-2.330TTM-0.031-2.299
TTM-0.031YOY13.031-13.062
TTM-0.0315Y2.023-2.055
5Y2.02310Y1.706+0.317
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3300.003-2.333
TTM-0.0310.019-0.050
YOY13.0310.042+12.989
5Y2.0230.020+2.003
10Y1.7060.017+1.689

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Clinuvel is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.84 means the investor is paying $5.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Clinuvel Pharmaceuticals Ltd:

  • The EOD is 7.477. Seems overpriced? -1
  • The MRQ is 5.844. Seems overpriced? -1
  • The TTM is 12.029. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.477MRQ5.844+1.633
MRQ5.844TTM12.029-6.185
TTM12.029YOY15.544-3.515
TTM12.0295Y16.880-4.852
5Y16.88010Y13.282+3.598
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.4771.843+5.634
MRQ5.8441.961+3.883
TTM12.0292.789+9.240
YOY15.5443.538+12.006
5Y16.8802.782+14.098
10Y13.2822.419+10.863

2.4. Latest News of Clinuvel Pharmaceuticals Ltd

Does Clinuvel Pharmaceuticals Ltd still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Clinuvel Pharmaceuticals Ltd to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-20
01:53
Clinuvel Pharmaceuticals' (ASX:CUV) earnings growth rate lags the 25% CAGR delivered to shareholdersRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Clinuvel Pharmaceuticals Ltd.

3.1. Funds holding Clinuvel Pharmaceuticals Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.3099999-647827--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.5-246587--
2021-02-28iShares Core MSCI EAFE ETF0.37-182269--
2021-02-28iShares MSCI EAFE Small Cap ETF0.36000002-177672--
2020-12-31College Retirement Equities Fund-Stock Account0.23-112159--
2021-01-31DFA Asia Pacific Small Company Series0.22-108279--
2020-10-31Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index0.19-95629--
2020-12-31Bernstein Fund, Inc.-International Small Cap Portfolio0.18000001-87490--
2020-11-30Schwab Strategic Tr-Schwab International Small Cap Equity ETF0.11-53643--
2021-01-31DFA International Core Equity Portfolio0.090000004-42853--
Total 3.55999993401754408  

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Clinuvel Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--2.5412.231+14%1.664+53%1.371+85%0.860+196%
Book Value Per Share Growth--0.3480.136+156%0.117+196%0.102+242%0.052+563%
Current Ratio--10.23712.788-20%10.581-3%12.631-19%8.291+23%
Debt To Asset Ratio--0.1280.091+41%0.103+25%0.085+51%0.115+11%
Debt To Equity Ratio--0.1460.100+46%0.114+28%0.093+58%0.134+10%
Dividend Per Share--0.0250.013+100%0.011+129%0.008+197%0.004+493%
Eps--0.1520.106+43%0.125+22%0.111+37%0.057+165%
Eps Growth---15.0082.529-693%6.552-329%34.211-144%-1.868-88%
Gains Per Share--0.3730.148+152%0.128+191%0.110+239%0.057+558%
Gross Profit Margin--1.0001.0000%0.972+3%0.953+5%1.014-1%
Net Profit Margin--0.3630.150+142%0.370-2%0.384-6%-1.189+428%
Operating Margin--0.3170.127+149%0.228+39%0.346-8%-1.394+539%
Operating Ratio--0.0320.008+281%0.130-75%0.369-91%0.596-95%
Pb Ratio7.477+22%5.84412.029-51%15.544-62%16.880-65%13.282-56%
Pe Ratio44.741+22%34.96854.596-36%56.302-38%52.786-34%25.184+39%
Peg Ratio---2.330-0.031-99%13.031-118%2.023-215%1.706-237%
Price Per Share19.000+22%14.85025.845-43%25.850-43%21.941-32%12.672+17%
Quick Ratio--10.0286.842+47%5.703+76%6.554+53%4.564+120%
Return On Assets--0.1040.062+69%0.099+5%0.071+47%-0.008+107%
Return On Equity--0.1200.068+75%0.110+8%0.078+54%-0.014+111%
 EOD+0 -3MRQTTM+14 -5YOY+15 -55Y+14 -610Y+14 -6

4.2. Fundamental Score

Let's check the fundamental score of Clinuvel Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.741
Price to Book Ratio (EOD)Between0-17.477
Net Profit Margin (MRQ)Greater than00.363
Operating Margin (MRQ)Greater than00.317
Quick Ratio (MRQ)Greater than110.028
Current Ratio (MRQ)Greater than110.237
Debt to Asset Ratio (MRQ)Less than10.128
Debt to Equity Ratio (MRQ)Less than10.146
Return on Equity (MRQ)Greater than0.150.120
Return on Assets (MRQ)Greater than0.050.104
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Clinuvel Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.133
Ma 20Greater thanMa 5019.758
Ma 50Greater thanMa 10019.172
Ma 100Greater thanMa 20017.460
OpenGreater thanClose18.730
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets143,950
Total Liabilities18,390
Total Stockholder Equity125,559
 As reported
Total Liabilities 18,390
Total Stockholder Equity+ 125,559
Total Assets = 143,950

Assets

Total Assets143,950
Total Current Assets140,583
Long-term Assets140,583
Total Current Assets
Cash And Cash Equivalents 121,509
Net Receivables 16,202
Inventory 1,832
Other Current Assets 1,039
Total Current Assets  (as reported)140,583
Total Current Assets  (calculated)140,583
+/-0
Long-term Assets
Property Plant Equipment 2,700
Goodwill 185
Other Assets 482
Long-term Assets  (as reported)3,367
Long-term Assets  (calculated)3,367
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,732
Long-term Liabilities4,658
Total Stockholder Equity125,559
Total Current Liabilities
Short-term Debt 315
Accounts payable 259
Other Current Liabilities 13,158
Total Current Liabilities  (as reported)13,732
Total Current Liabilities  (calculated)13,732
+/-0
Long-term Liabilities
Long term Debt Total 941
Other Liabilities 3,717
Long-term Liabilities  (as reported)4,658
Long-term Liabilities  (calculated)4,658
+/- 0
Total Stockholder Equity
Common Stock151,849
Retained Earnings -38,402
Other Stockholders Equity 12,112
Total Stockholder Equity (as reported)125,559
Total Stockholder Equity (calculated)125,559
+/-0
Other
Capital Stock151,849
Cash And Equivalents121,509
Cash and Short Term Investments 121,509
Common Stock Shares Outstanding 49,410
Liabilities and Stockholders Equity 143,950
Net Debt -120,253
Net Invested Capital 125,559
Net Tangible Assets 125,374
Net Working Capital 126,850
Short Long Term Debt Total 1,257



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-31
> Total Assets 
0
0
14,128
0
0
0
13,769
12,204
12,204
10,520
10,520
8,829
8,829
8,066
8,066
12,586
12,586
10,247
10,247
0
0
10,056
10,056
16,562
16,562
17,071
17,071
45,658
45,658
67,825
67,825
61,711
61,711
54,971
54,971
47,941
47,941
41,614
41,614
35,748
35,748
29,507
29,507
24,885
24,885
20,166
20,165
13,610
13,610
15,995
15,995
12,772
12,772
15,815
15,815
12,717
12,717
17,154
17,154
14,598
14,598
13,644
13,644
11,281
11,281
20,138
20,138
22,841
22,841
28,607
28,607
30,156
30,156
42,905
42,905
45,708
45,708
62,345
62,345
62,077
62,077
0
81,542
0
87,881
0
108,568
0
115,653
0
143,950
143,9500115,6530108,568087,881081,542062,07762,07762,34562,34545,70845,70842,90542,90530,15630,15628,60728,60722,84122,84120,13820,13811,28111,28113,64413,64414,59814,59817,15417,15412,71712,71715,81515,81512,77212,77215,99515,99513,61013,61020,16520,16624,88524,88529,50729,50735,74835,74841,61441,61447,94147,94154,97154,97161,71161,71167,82567,82545,65845,65817,07117,07116,56216,56210,05610,0560010,24710,24712,58612,5868,0668,0668,8298,82910,52010,52012,20412,20413,76900014,12800
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
4,483
0
0
0
2,748
0
0
0
5,682
0
0
0
5,246
0
0
0
13,917
0
0
0
65,317
0
0
0
53,120
0
0
0
40,594
0
0
0
29,158
0
0
0
19,932
0
0
0
15,807
0
0
0
15,668
0
0
0
17,039
0
0
0
13,575
0
0
20,000
19,974
22,669
22,669
28,470
28,470
30,027
30,027
42,269
42,269
44,916
44,916
61,153
61,153
60,791
60,791
75,156
75,156
80,286
80,286
102,848
102,848
113,111
113,111
140,583
140,583
140,583140,583113,111113,111102,848102,84880,28680,28675,15675,15660,79160,79161,15361,15344,91644,91642,26942,26930,02730,02728,47028,47022,66922,66919,97420,0000013,57500017,03900015,66800015,80700019,93200029,15800040,59400053,12000065,31700013,9170005,2460005,6820002,7480004,4830000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
4,414
0
0
0
2,612
0
0
0
5,480
0
0
0
4,763
0
0
0
8,606
0
0
0
33,842
0
0
0
25,752
0
0
0
21,711
0
0
0
19,415
0
0
0
12,178
0
0
0
12,719
0
0
0
12,569
0
0
0
14,626
0
0
0
10,572
0
0
14,000
13,845
19,550
19,550
23,752
23,752
27,939
27,939
36,198
36,198
42,826
42,826
54,269
54,269
57,432
57,432
0
66,747
0
72,918
0
82,691
0
98,992
0
121,509
121,509098,992082,691072,918066,747057,43257,43254,26954,26942,82642,82636,19836,19827,93927,93923,75223,75219,55019,55013,84514,0000010,57200014,62600012,56900012,71900012,17800019,41500021,71100025,75200033,8420008,6060004,7630005,4800002,6120004,4140000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,024
0
0
0
28,512
0
0
0
25,048
0
0
0
16,043
0
0
0
7,588
0
0
0
5,321
0
0
0
454
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000004540005,3210007,58800016,04300025,04800028,5120002,02400000000000000000000000000
       Net Receivables 
0
0
57
0
0
0
35
46
46
30
30
18
18
31
31
11
11
78
78
0
0
137
137
259
259
233
233
347
347
242
241
305
305
616
616
363
363
212
212
269
269
363
363
468
468
974
974
99
99
1,007
1,007
891
891
1,743
1,743
1,436
1,436
1,585
1,585
1,695
1,695
1,961
1,960
2,069
2,069
4,824
4,824
1,509
1,509
3,239
3,239
584
584
5,090
5,090
1,037
1,037
4,156
4,156
643
643
6,613
6,613
4,836
4,836
16,089
16,089
10,092
10,092
16,202
16,202
16,20216,20210,09210,09216,08916,0894,8364,8366,6136,6136436434,1564,1561,0371,0375,0905,0905845843,2393,2391,5091,5094,8244,8242,0692,0691,9601,9611,6951,6951,5851,5851,4361,4361,7431,7438918911,0071,007999997497446846836336326926921221236336361661630530524124234734723323325925913713700787811113131181830304646350005700
       Other Current Assets 
0
0
56
0
0
0
13
66
66
39
39
162
162
106
106
73
73
124
124
0
0
268
314
1,737
1,737
2,434
2,474
2,135
2,135
2,722
2,722
2,247
2,247
1,703
1,703
2,820
2,820
2,628
2,628
2,377
2,377
1,791
1,791
1,594
1,594
1,460
1,460
1,556
1,556
1,627
1,627
1,599
1,599
1,357
1,357
1,404
1,404
828
828
839
839
205
205
287
287
223
223
256
256
237
237
419
419
339
339
0
607
0
592
0
806
0
509
0
1,215
0
882
879
879
0
1,039
1,039087987988201,215050908060592060703393394194192372372562562232232872872052058398398288281,4041,4041,3571,3571,5991,5991,6271,6271,5561,5561,4601,4601,5941,5941,7911,7912,3772,3772,6282,6282,8202,8201,7031,7032,2472,2472,7222,7222,1352,1352,4742,4341,7371,73731426800124124737310610616216239396666130005600
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
6,037
0
0
0
5,318
0
0
0
4,565
0
0
0
4,810
0
0
0
3,154
0
0
0
2,508
0
0
0
1,851
0
0
0
1,020
0
0
0
349
0
0
0
233
0
0
0
188
0
0
0
146
0
0
0
114
0
0
0
69
0
0
0
165
0
0
0
137
0
0
0
636
0
0
0
1,193
0
0
0
6,386
0
0
0
5,719
0
0
0
3,367
3,3670005,7190006,3860001,193000636000137000165000690001140001460001880002330003490001,0200001,8510002,5080003,1540004,8100004,5650005,3180006,0370000000000
       Property Plant Equipment 
0
0
94
0
0
0
116
127
127
142
142
177
177
147
147
141
141
120
120
0
0
249
249
234
234
222
222
313
313
332
332
423
423
431
431
418
418
357
357
339
339
322
322
345
345
215
215
189
189
179
179
167
167
146
146
129
129
115
114
84
84
69
69
68
68
165
165
171
171
137
137
129
129
169
169
326
326
707
707
801
801
2,389
2,389
2,922
2,922
2,603
2,603
2,282
2,282
2,700
2,700
2,7002,7002,2822,2822,6032,6032,9222,9222,3892,389801801707707326326169169129129137137171171165165686869698484114115129129146146167167179179189189215215345345322322339339357357418418431431423423332332313313222222234234249249001201201411411471471771771421421271271160009400
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185
185
185
185
185
185
185
185
0
185
0
185
0
185
0
185
0
185
185018501850185018501851851851851851851851850000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
7,352
0
0
0
6,624
6,256
6,256
5,896
5,896
5,525
5,525
5,171
5,171
4,810
4,810
4,445
4,445
0
0
4,561
4,561
4,367
4,367
2,932
2,932
2,604
2,604
2,176
2,176
1,798
1,798
1,420
1,420
1,041
1,041
663
663
285
285
28
28
23
23
18
18
14
14
9
9
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185
185
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000018518500000000000000000000559914141818232328282852856636631,0411,0411,4201,4201,7981,7982,1762,1762,6042,6042,9322,9324,3674,3674,5614,561004,4454,4454,8104,8105,1715,1715,5255,5255,8965,8966,2566,2566,6240007,35200
       Other Assets 
0
0
7,352
0
0
0
6,624
6,256
6,256
5,896
5,896
5,525
5,525
5,171
5,171
4,810
4,810
4,445
4,445
0
0
4,561
4,561
4,367
4,367
2,932
2,932
2,604
2,604
2,176
2,176
1,798
1,798
1,420
1,420
1,041
1,041
663
663
285
285
28
28
23
23
18
18
14
14
9
9
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
282
282
282
282
301
301
301
301
3,812
3,812
4,488
4,488
2,931
2,931
76
76
482
482
48248276762,9312,9314,4884,4883,8123,81230130130130128228228228200000000000000000000559914141818232328282852856636631,0411,0411,4201,4201,7981,7982,1762,1762,6042,6042,9322,9324,3674,3674,5614,561004,4454,4454,8104,8105,1715,1715,5255,5255,8965,8966,2566,2566,6240007,35200
> Total Liabilities 
0
0
124
0
0
0
318
255
255
211
211
391
391
536
535
635
635
1,392
1,392
0
0
2,601
2,601
2,747
2,747
3,082
3,082
1,356
1,356
2,433
2,433
2,901
2,901
3,156
3,156
5,376
5,376
4,563
4,563
2,796
2,796
3,081
3,081
2,820
2,820
3,757
3,757
2,595
2,595
2,358
2,358
3,024
3,024
1,976
1,976
1,854
1,854
1,726
1,726
1,813
1,813
2,439
2,439
2,494
2,494
2,304
2,304
2,288
2,288
3,163
3,163
2,783
2,809
3,489
3,489
2,581
2,581
5,166
5,166
4,050
4,050
0
7,873
0
9,796
0
9,830
0
8,362
0
18,390
18,39008,36209,83009,79607,87304,0504,0505,1665,1662,5812,5813,4893,4892,8092,7833,1633,1632,2882,2882,3042,3042,4942,4942,4392,4391,8131,8131,7261,7261,8541,8541,9761,9763,0243,0242,3582,3582,5952,5953,7573,7572,8202,8203,0813,0812,7962,7964,5634,5635,3765,3763,1563,1562,9012,9012,4332,4331,3561,3563,0823,0822,7472,7472,6012,601001,3921,39263563553553639139121121125525531800012400
   > Total Current Liabilities 
0
0
124
0
0
0
318
255
255
211
211
391
391
536
535
635
635
1,370
1,370
0
0
2,577
2,577
2,732
2,732
3,067
3,067
1,340
1,340
2,428
2,428
2,897
2,897
3,147
3,147
5,369
5,369
4,544
4,544
2,761
2,761
3,040
3,040
2,770
2,770
3,717
3,717
2,561
2,561
2,339
2,339
2,998
2,998
1,946
1,946
1,814
1,814
1,718
1,718
1,791
1,791
2,435
2,435
2,490
2,490
2,288
2,288
2,273
2,273
3,148
3,148
2,766
2,766
3,471
3,471
2,561
2,561
4,960
4,960
3,952
3,952
6,660
6,660
8,587
8,587
8,707
8,707
7,374
7,374
13,732
13,732
13,73213,7327,3747,3748,7078,7078,5878,5876,6606,6603,9523,9524,9604,9602,5612,5613,4713,4712,7662,7663,1483,1482,2732,2732,2882,2882,4902,4902,4352,4351,7911,7911,7181,7181,8141,8141,9461,9462,9982,9982,3392,3392,5612,5613,7173,7172,7702,7703,0403,0402,7612,7614,5444,5445,3695,3693,1473,1472,8972,8972,4282,4281,3401,3403,0673,0672,7322,7322,5772,577001,3701,37063563553553639139121121125525531800012400
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,024
0
0
0
28,512
0
0
0
25,048
0
0
0
16,043
0
0
0
7,588
0
0
0
5,321
0
0
0
454
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
261
0
0
0
212
0
0
0
258
0
0
0
315
3150002580002120002610000000000000000000000000004540005,3210007,58800016,04300025,04800028,5120002,02400000000000000000000000000
       Accounts payable 
0
0
9
0
0
0
183
0
0
70
70
0
0
236
236
0
0
1,180
1,180
0
0
2,346
2,346
2,685
2,685
2,535
2,535
1,280
1,280
1,597
1,597
0
0
734
734
0
0
2,056
2,056
0
0
569
569
2,546
2,546
1,697
1,697
2,342
2,342
839
839
2,708
2,708
184
184
1,269
1,269
179
179
1,141
1,141
261
261
1,848
1,848
231
231
1,510
1,510
580
580
1,894
1,894
429
429
1,565
1,565
1,500
1,500
2,242
2,242
1,430
1,430
4,991
4,991
2,324
2,324
3,762
3,762
259
259
2592593,7623,7622,3242,3244,9914,9911,4301,4302,2422,2421,5001,5001,5651,5654294291,8941,8945805801,5101,5102312311,8481,8482612611,1411,1411791791,2691,2691841842,7082,7088398392,3422,3421,6971,6972,5462,546569569002,0562,05600734734001,5971,5971,2801,2802,5352,5352,6852,6852,3462,346001,1801,1800023623600707000183000900
       Other Current Liabilities 
0
0
115
0
0
0
135
255
255
141
141
391
391
300
300
635
635
191
191
0
0
232
231
47
47
531
532
60
60
831
831
2,897
2,897
2,413
2,413
5,369
5,369
2,488
2,488
2,761
2,761
2,471
2,471
224
224
2,019
2,020
219
219
1,500
1,500
290
290
1,763
1,762
545
545
1,540
1,540
650
650
2,175
2,175
642
642
2,057
2,057
764
764
2,568
2,568
873
873
2,071
3,042
0
0
2,133
3,199
0
0
3,342
5,018
0
0
2,428
6,125
3,345
3,345
10,298
13,158
13,15810,2983,3453,3456,1252,428005,0183,342003,1992,133003,0422,0718738732,5682,5687647642,0572,0576426422,1752,1756506501,5401,5405455451,7621,7632902901,5001,5002192192,0202,0192242242,4712,4712,7612,7612,4882,4885,3695,3692,4132,4132,8972,897831831606053253147472312320019119163563530030039139114114125525513500011500
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
0
0
0
24
0
0
0
15
0
0
0
5
0
0
0
9
0
0
0
19
0
0
0
41
0
0
0
40
0
0
0
19
0
0
0
29
0
0
0
8
0
0
0
3
0
0
0
15
0
0
0
15
0
0
0
18
0
0
0
205
0
0
0
1,213
0
0
0
1,123
0
0
0
4,658
4,6580001,1230001,21300020500018000150001500030008000290001900040000410001900090005000150002400022000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
171
0
64
0
1,107
0
1,136
0
1,045
0
903
0
941
941090301,04501,13601,1070640171000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
22
0
0
24
24
15
15
15
15
17
17
5
5
4
4
9
9
8
8
19
19
35
35
41
41
51
51
40
40
34
34
19
19
26
26
29
29
39
39
8
8
22
22
3
3
4
4
15
15
15
15
15
15
16
16
18
18
20
20
34
34
35
35
106
106
72
72
78
78
85
85
3,717
3,717
3,7173,717858578787272106106353534342020181816161515151515154433222288393929292626191934344040515141413535191988994455171715151515242400222200000000000000000
> Total Stockholder Equity
0
0
14,005
0
0
0
13,451
11,949
11,949
10,310
10,310
8,438
8,438
7,531
7,531
11,952
11,952
8,855
8,855
8,855
0
7,454
7,454
13,815
13,815
13,989
13,989
44,302
44,302
65,392
65,392
58,810
58,810
51,815
51,815
42,564
42,564
37,051
37,051
32,952
32,952
26,426
26,426
22,064
22,064
16,408
16,408
11,015
11,015
13,637
13,637
9,747
9,747
13,839
13,839
10,863
10,863
15,428
15,428
12,784
12,784
11,222
11,205
8,730
8,730
17,796
17,796
20,458
20,458
25,386
25,386
27,347
27,347
39,416
39,416
43,128
43,128
57,180
57,180
58,027
58,027
0
73,669
0
78,085
0
98,737
0
107,291
0
125,559
125,5590107,291098,737078,085073,669058,02758,02757,18057,18043,12843,12839,41639,41627,34727,34725,38625,38620,45820,45817,79617,7968,7308,73011,20511,22212,78412,78415,42815,42810,86310,86313,83913,8399,7479,74713,63713,63711,01511,01516,40816,40822,06422,06426,42626,42632,95232,95237,05137,05142,56442,56451,81551,81558,81058,81065,39265,39244,30244,30213,98913,98913,81513,8157,4547,45408,8558,8558,85511,95211,9527,5317,5318,4388,43810,31010,31011,94911,94913,45100014,00500
   Common Stock
0
0
14,379
0
0
0
15,383
15,382
15,382
15,383
15,382
15,382
15,382
16,580
16,580
24,808
24,808
25,494
25,494
0
0
35,123
35,123
46,495
46,495
52,726
52,726
86,914
86,914
112,814
112,813
112,814
112,814
113,223
113,222
113,221
113,221
113,221
113,221
113,221
113,221
113,228
113,228
113,276
113,276
113,339
113,339
113,364
113,364
119,323
119,323
119,884
119,884
126,710
126,710
126,710
126,710
133,567
133,567
133,817
133,817
138,465
138,465
138,465
138,465
146,765
146,765
148,396
148,396
148,413
148,413
148,413
148,413
148,615
148,615
148,982
148,982
151,314
151,314
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849
151,849151,849151,849151,849151,849151,849151,849151,849151,849151,849151,849151,849151,314151,314148,982148,982148,615148,615148,413148,413148,413148,413148,396148,396146,765146,765138,465138,465138,465138,465133,817133,817133,567133,567126,710126,710126,710126,710119,884119,884119,323119,323113,364113,364113,339113,339113,276113,276113,228113,228113,221113,221113,221113,221113,221113,221113,222113,223112,814112,814112,813112,81486,91486,91452,72652,72646,49546,49535,12335,1230025,49425,49424,80824,80816,58016,58015,38215,38215,38215,38315,38215,38215,38300014,37900
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-80
0
0
0
-123
0
0
0
-152
0
0
0
-164
0
0
0
1,153
0
0
0
1,645
0
0
0
1,764
0
0
0
2,167
0
0
0
2,169
0
0
0
3,214
0
0
0
1,821
0
0
0
1,251
0
0
0
1,438
0
0
0
2,698
0
0
0
4,095
0
0
0
2,820
0
0
0
3,482
0
0
0
1,352
0
0
0
1,856
0
0
0
5,018
0
0
0
12,112
12,1120005,0180001,8560001,3520003,4820002,8200004,0950002,6980001,4380001,2510001,8210003,2140002,1690002,1670001,7640001,6450001,153000-164000-152000-123000-800000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,568
2,568
2,820
2,820
3,282
403
3,482
618
3,708
741
1,352
698
1,802
1,802
1,856
1,856
2,606
2,606
5,018
5,018
8,923
8,923
12,112
12,112
12,11212,1128,9238,9235,0185,0182,6062,6061,8561,8561,8021,8026981,3527413,7086183,4824033,2822,8202,8202,5682,56800000000000000000000000000000000000000000000000000000000800000000000



Balance Sheet

Currency in AUD. All numbers in thousands.